
664.8MUSD

See which Billionaires own this investment
Type
Common Stock
Exchange
NASDAQ
Currency Code
USD
Currency Name
US Dollar
Country Name
USA
Country ISO
US
ISIN
US83422E2046
CUSIP
83422E105
Sector
Healthcare
Industry
Biotechnology
Fiscal Year End
December
IPO date
-
Updated At
-
PE Ratio
-
PEG Ratio
-
Book Value
3.56
Dividend Share
-
Dividend Yield
-
Earnings Share
-1.89
Wall Street Target Price
18.71
EPS Estimate Current Year
-1.76
EPS Estimate Next Year
-1.71
EPS Estimate Current Quarter
-0.4683
EPS Estimate Next Quarter
-0.4813
Most Recent Quarter
-
Revenue TTM
0
Gross Profit TTM
-96,431,000
EBITDA
-210,524,000
Profit Margin
0.00%
Return On Assets TTM
-36.38%
Return On Equity TTM
-65.50%
Revenue Per Share TTM
0
Qtly Revenue Growth YOY
-100.00%
Diluted Eps TTM
-1.89
Qtly Earnings Growth YOY
0.00%
Trailing PE
0.00
Forward PE
0
Price Sales TTM
3.6454
Price Book MRQ
1.7772
Enterprise Value Revenue
1
Enterprise Value EBITDA
-3
903.08
3.20%227.40
2.97%965.00
0.55%314.92
0.35%900.30
0.00%139.16
0.00%528.21
-4.77%355.10
-2.26%34.64
-2.01%153.70
-1.47%